Design and synthesis of HDAC inhibitors to enhance the therapeutic effect of diffuse large B-cell lymphoma by improving metabolic stability and pharmacokinetic characteristics-Reference-Cited by-同舟云学术

Design and synthesis of HDAC inhibitors to enhance the therapeutic effect of diffuse large B-cell lymphoma by improving metabolic stability and pharmacokinetic characteristics

Published:2022-02 Issue: Volume:229 Page:114049
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Cui Hao,Hong Qianqian,Wei Ran,Li Hongmei^ORCID,Wan Chunyang,Chen Xin^ORCID,Zhao Shuang,Bu Haizhi,Zhang Bingxu,Yang Dexiao,Lu Tao,Chen Yadong,Zhu Yong^ORCID

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference36 articles.

1. FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma;Mann;Oncol.,2007

2. Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma;Santo;Blood,2012

3. Romidepsin: a novel histone deacetylase inhibitor for cancer;Bertino;Expet Opin. Invest. Drugs,2011

4. Panobinostat: first global approval;Garnock-Jones;Drugs,2015

5. Phase I study of chidamide (CS055/HBI-8000), a new histone deacetylase inhibitor, in patients with advanced solid tumors and lymphomas;Dong;Cancer Chemother. Pharmacol.,2012

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Histone deacetylases and their inhibitors in inflammatory diseases;Biomedicine & Pharmacotherapy;2024-10

2. Discovery of a Novel Benzimidazole Derivative Targeting Histone Deacetylase to Induce Ferroptosis and Trigger Immunogenic Cell Death;Journal of Medicinal Chemistry;2024-08-15

3. The golden key to open mystery boxes of SMARCA4-deficient undifferentiated thoracic tumor: focusing immunotherapy, tumor microenvironment and epigenetic regulation;Cancer Gene Therapy;2024-02-13

4. Design and synthesis of 1H-benzo[d]imidazole selective HDAC6 inhibitors with potential therapy for multiple myeloma;European Journal of Medicinal Chemistry;2023-12

5. Technologies of targeting histone deacetylase in drug discovery: Current progress and emerging prospects;European Journal of Medicinal Chemistry;2023-12